![]() |
市场调查报告书
商品编码
1955091
全球验光仪市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034)Phoropters Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
全球验光仪市场在眼科诊断中发挥着至关重要的作用,能够精确测量近视、远视、散光和老花眼等屈光不正。 验光仪被眼科医生和验光师广泛用于日常眼科检查,以确定准确的视力矫正处方。
市场规模及预测
根据 Fortune Business Insights 的数据,2025 年全球验光仪市场规模为 1.6075 亿美元。 预计到 2026 年市场规模将成长至 1.6786 亿美元,并在 2034 年进一步达到 2.3379 亿美元,在预测期(2026-2034 年)内复合年增长率 (CAGR) 为 4.23%。
这一稳定成长得益于人们对眼部健康的日益重视、屈光不正盛行率的上升以及全球眼科医疗基础设施的扩展。
市场概览
验光仪是一种眼科设备,由镜片、棱镜和柱镜组成,用于透过测量光线在视网膜上的聚焦情况来评估屈光不正。眼科医疗专业人员将验光仪作为视力测试的标准诊断工具。
生活方式的改变、长时间接触电子萤幕以及人口老化显着增加了人们对定期眼科检查的需求。 近期发布的临床指南,例如美国验光协会 (AOA) 2023 年建议 18 至 64 岁人群每年进行眼科检查,进一步推动了市场扩张。 主要市场驱动因素 主要成长驱动因素之一是全球屈光不正盛行率的上升。本报告引用的研究表明,儿童和成人近视和远视病例均增加。此外,糖尿病等慢性疾病(高血糖会导致屈光改变)也扩大了需要定期进行眼科检查的患者族群。 另一个重要因素是,由于医疗保健支出增加以及政府为加强眼科医疗服务而采取的举措,验光师和眼科医生的数量也在不断增长。人口老化,尤其是在已开发市场,也推动了对眼科诊断设备(包括验光仪)的需求。 市场趋势 影响验光仪市场的一个关键趋势是,人们越来越倾向于选择自动验光仪而非手动验光仪。自动验光仪具有许多优势,例如缩短检查时间、提高准确性、与电子病历无缝整合以及减轻临床医生的体力负担。
先进的数位系统,例如配备触控萤幕介面和预设检查功能的自动验光仪,正日益被应用于先进的医疗环境中,从而巩固了自动化设备在市场上的主导地位。
限制因子
儘管需求强劲,但自动验光仪的高昂成本仍然是一个主要的限制因素,尤其是在新兴经济体。自动化系统的成本,包括安装和维护费用,限制了小型诊所和预算有限的医疗机构采用这些系统。这种价格敏感性持续阻碍中低收入地区的市场渗透。
依产品类型划分,验光仪分为手动型和自动型。自动型验光仪凭藉其在效率、准确性和节省时间方面的优势,占了最大的市场占有率并主导着市场。 由于价格低廉,手动验光仪仍在小型诊所中使用。
依最终用户划分,眼科诊所占了大部分市场占有率。这主要归功于个别诊所的增加以及对门诊眼科的日益重视。由于屈光不正和眼部疾病负担的加重,医院也对市场做出了显着贡献。
北美将在2025年以41.85%的市占率引领全球验光仪市场。这得益于该地区数位眼部疲劳的高发生率、完善的医保报销体係以及成熟的眼科医疗专业人员网络。美国仍然是该地区最大的贡献者。
欧洲将占第二大市场占有率,这得益于监管意识提升计划和早期眼科检查倡议。亚太地区正经历显着成长,这得益于医疗保健投资的增加、国内製造商竞争力的增强以及日本、中国、印度和其他国家对先进眼科技术的日益普及。
The global phoropter market plays a critical role in ophthalmic diagnostics, enabling accurate measurement of refractive errors such as myopia, hyperopia, astigmatism, and presbyopia. Phoropters are widely used by optometrists and ophthalmologists during routine eye examinations to determine precise vision prescriptions.
Market Size & Forecast
According to Fortune Business Insights, the global phoropter market was valued at USD 160.75 million in 2025. The market is projected to grow to USD 167.86 million in 2026 and further reach USD 233.79 million by 2034, registering a CAGR of 4.23% during the forecast period (2026-2034).
This steady growth is supported by rising awareness of eye health, increasing prevalence of refractive disorders, and the expansion of ophthalmic care infrastructure globally.
Market Overview
A phoropter is an ophthalmic device comprising lenses, prisms, and cylinders used to evaluate refractive errors by determining how light focuses on the retina. Eye care professionals rely on phoropters as a standard diagnostic tool during vision testing.
The demand for routine eye examinations has increased significantly due to lifestyle changes, prolonged digital screen exposure, and a growing elderly population. Updated clinical guidelines, such as the American Optometric Association's 2023 recommendation for annual eye exams for individuals aged 18-64, further support market expansion.
Key Market Drivers
One of the primary growth drivers is the rising prevalence of refractive errors worldwide. Studies cited in the report indicate increasing cases of myopia and hyperopia across both pediatric and adult populations. Additionally, chronic conditions such as diabetes mellitus, which are linked to refractive changes due to hyperglycemia, are expanding the patient pool requiring regular eye examinations.
Another significant factor is the increasing number of optometrists and ophthalmologists, driven by higher healthcare expenditure and government initiatives to strengthen eye care services. The aging population, particularly in developed markets, is also increasing demand for ophthalmic diagnostics, including phoropters.
Market Trends
A major trend shaping the phoropter market is the growing preference for automated phoropters over manual systems. Automated phoropters offer faster testing, higher accuracy, seamless integration with electronic medical records, and reduced physical workload for clinicians.
Advanced digital systems, such as automated refraction units with touchscreen interfaces and pre-programmed tests, are increasingly adopted in developed healthcare settings, supporting the dominance of automated devices in the market.
Restraining Factors
Despite strong demand, high costs associated with automated phoropters remain a key restraint, especially in emerging economies. The cost of automated systems, including installation and maintenance, limits adoption among small clinics and budget-constrained healthcare facilities. This price sensitivity continues to restrict market penetration in low- and middle-income regions.
By Product Type, the market is segmented into manual and automated phoropters. The automated segment dominated the market, accounting for the largest share due to efficiency, accuracy, and time-saving benefits. Manual phoropters continue to be used in smaller clinics due to their lower cost.
By End User, ophthalmic clinics held the dominant market share, supported by the rising number of private practices and increasing focus on outpatient eye care. Hospitals also contribute significantly due to the growing burden of refractive and ocular disorders.
North America dominated the global phoropter market with a 41.85% share in 2025, driven by high prevalence of digital eye strain, strong reimbursement frameworks, and a well-established network of eye care professionals. The U.S. remains the largest contributor in the region.
Europe held the second-largest share, supported by regulatory awareness programs and early eye examination initiatives. Asia Pacific is witnessing notable growth due to rising healthcare investment, strong domestic manufacturers, and increasing adoption of advanced ophthalmic technologies in countries such as Japan, China, and India.
Competitive Landscape
The market is partially fragmented, with key players including Reichert, Inc. (AMETEK, Inc.), NIDEK CO., LTD., ZEISS, EssilorLuxottica, Topcon Corporation, Visionix, and Rexxam Co., Ltd. These companies focus on product innovation, strategic collaborations, and geographic expansion to strengthen their market presence.
Conclusion
The global phoropter market demonstrates stable and sustained growth from 2025 to 2034, increasing from USD 160.75 million in 2025 to USD 233.79 million by 2034. Growth is driven by rising refractive error prevalence, increasing demand for routine eye examinations, technological advancements in automated phoropters, and expansion of ophthalmic clinics. While high equipment costs limit adoption in emerging regions, continued innovation and healthcare investments are expected to support long-term market expansion.
Segmentation By Product Type
By End User
By Region